0001654954-21-011064.txt : 20211013 0001654954-21-011064.hdr.sgml : 20211013 20211013170057 ACCESSION NUMBER: 0001654954-21-011064 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211011 FILED AS OF DATE: 20211013 DATE AS OF CHANGE: 20211013 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brannan Michael A. CENTRAL INDEX KEY: 0001807248 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22893 FILM NUMBER: 211321775 MAIL ADDRESS: STREET 1: C/O AEHR TEST SYSTEMS STREET 2: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEHR TEST SYSTEMS CENTRAL INDEX KEY: 0001040470 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 942424084 STATE OF INCORPORATION: CA FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 BUSINESS PHONE: 5106239400 MAIL ADDRESS: STREET 1: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2021-10-11 0001040470 AEHR TEST SYSTEMS AEHR 0001807248 Brannan Michael A. C/O AEHR TEST SYSTEMS 400 KATO TERRACE FREMONT CA 94539 true V.P. of Operations Common Stock 2021-10-11 4 M false 14000 1.2200 A 28826 D Common Stock 2021-10-11 4 S false 17000 18.8000 D 11826 D Common Stock 2021-10-12 4 M false 14125 1.2200 A 25951 D Incentive Stock Option (right to buy) 1.2200 2021-10-11 4 M false 14000 0.0000 D 2020-04-16 2027-03-16 Common Stock 14000 61000 D Incentive Stock Option (right to buy) 1.2200 2021-10-12 4 M false 14125 0.0000 D 2020-04-16 2027-03-16 Common Stock 14125 46875 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.35 to $19.67, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. The amount reported includes shares subject to unvested restricted stock units. One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. /s/ Michael A. Brannan 2021-10-13